A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMC-003 for Injection in Healthy Postmenopausal Women

Clinical trial NCT07118085 · RECRUITING

Trial details

NCT number: NCT07118085
Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Postmenopausal Women

Start date: 2025-08-18
Primary completion: 2027-05-20
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.